Literature DB >> 26572976

Telomere Repeat-Binding Factor 2 Is Responsible for the Telomere Attachment to the Nuclear Membrane.

Nadya V Ilicheva1, Olga I Podgornaya2, Alex P Voronin3.   

Abstract

Telomeres are nucleoprotein structures that specify ends of eukaryotic chromosomes. They enable complete DNA replication, protect chromosomes from end-to-end fusions, and help organize chromatin structure. These functions are mediated by special telomeric proteins. TRF2 (telomeric repeat-binding factor 2) is an essential component of shelterin, a telomere-binding protein complex. TRF2 induces formation of a special structure of telomeric DNA, counteracts activation of double-strand break response pathway and ataxia telangiectasia mutated kinase pathway at telomeres. Some line of evidence implicates TRF2 in interactions with the nuclear envelope (NE). TRF2 is tightly bound to the nuclear membrane in frog oocytes nucleus, and it was found colocalized with NE or its remnants in mouse cells. Computer analysis of TRF2 amino acid sequence has shown that TRF2 possesses motifs, which resemble rod domain characteristic of intermediate filament proteins. These observations suggest that TRF2 is a good candidate for the attachment of telomeres to the NE in somatic cells.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin organization; Nuclear envelope; Shelterin; TRF2; Telomeres

Mesh:

Substances:

Year:  2015        PMID: 26572976     DOI: 10.1016/bs.apcsb.2015.06.009

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  8 in total

1.  Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.

Authors:  Priyanka Banerjee; Elizabeth A Olmsted-Davis; Anita Deswal; Minh Th Nguyen; Efstratios Koutroumpakis; Nicholas L Palaskas; Steven H Lin; Sivareddy Kotla; Cielito Reyes-Gibby; Sai-Ching J Yeung; Syed Wamique Yusuf; Momoko Yoshimoto; Michihiro Kobayashi; Bing Yu; Keri Schadler; Joerg Herrmann; John P Cooke; Abhishek Jain; Eduardo Chini; Nhat-Tu Le; Jun-Ichi Abe
Journal:  J Cardiovasc Aging       Date:  2022-04-29

2.  Decreased expression of TERT and telomeric proteins as human ovaries age may cause telomere shortening.

Authors:  Fatma Uysal; Esra Gozde Kosebent; Havva Serap Toru; Saffet Ozturk
Journal:  J Assist Reprod Genet       Date:  2020-08-27       Impact factor: 3.412

3.  TERRA G-quadruplex RNA interaction with TRF2 GAR domain is required for telomere integrity.

Authors:  Yang Mei; Zhong Deng; Olga Vladimirova; Nitish Gulve; F Brad Johnson; William C Drosopoulos; Carl L Schildkraut; Paul M Lieberman
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.996

4.  Increase in lamin B1 promotes telomere instability by disrupting the shelterin complex in human cells.

Authors:  Gaëlle Pennarun; Julien Picotto; Laure Etourneaud; Anna-Rita Redavid; Anaïs Certain; Laurent R Gauthier; Paula Fontanilla-Ramirez; Didier Busso; Caroline Chabance-Okumura; Benoît Thézé; François D Boussin; Pascale Bertrand
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

5.  Nucleolus-like body of mouse oocytes contains lamin A and B and TRF2 but not actin and topo II.

Authors:  Galina N Pochukalina; Nadya V Ilicheva; Olga I Podgornaya; Alexey P Voronin
Journal:  Mol Cytogenet       Date:  2016-06-24       Impact factor: 2.009

6.  Mouse chromocenters DNA content: sequencing and in silico analysis.

Authors:  Dmitrii I Ostromyshenskii; Ekaterina N Chernyaeva; Inna S Kuznetsova; Olga I Podgornaya
Journal:  BMC Genomics       Date:  2018-02-20       Impact factor: 3.969

7.  The karyosphere capsule in Rana temporaria oocytes contains structural and DNA-binding proteins.

Authors:  Nadya Ilicheva; Olga Podgornaya; Dmitry Bogolyubov; Galina Pochukalina
Journal:  Nucleus       Date:  2018       Impact factor: 4.197

8.  The Long Linker Region of Telomere-Binding Protein TRF2 Is Responsible for Interactions with Lamins.

Authors:  Aleksandra O Travina; Nadya V Ilicheva; Alexey G Mittenberg; Sergey V Shabelnikov; Anastasia V Kotova; Olga I Podgornaya
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.